Document is current
Any future updates will be listed below
-
Authors
Vodstrcil, Lenka A. http://orcid.org/0000-0003-3679-9195
Muzny, Christina A.
Plummer, Erica L.
Sobel, Jack D.
Bradshaw, Catriona S.
-
Funding
Funding for this research was provided by:
national health and medical research council (GNT1173361)
national institute of allergy and infectious diseases (R01AI146065-01A1)
- License Information
-
More Information
Article History
Received: 18 June 2021
Accepted: 28 July 2021
First Online: 2 September 2021
Declarations
:
: Not applicable
: Not applicable
: L.A.V. and C.S.B. receive funding from the Australian National Health and Medical Research Council for research pertaining to bacterial vaginosis. Melbourne Sexual Health Centre has received fees for advice on clinical trials on bacterial vaginosis, which is unrelated to this work. C.A.M is a consultant for Lupin Pharmaceuticals, BioFire Diagnostics, Cepheid, and PhagoMed. C.A.M has also received research funding support from Lupin Pharmaceuticals as well as speaker honoraria from Abbott Molecular, Cepheid, Roche Diagnostics, and Becton Dickinson. J.D.S has served as a consultant for Scynexis Pharmaceuticals and Mycovia Pharmaceutical.
